These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15988389)

  • 1. Syndromes of thyroid hormone resistance.
    Beck-Peccoz P; Mannavola D; Persani L
    Ann Endocrinol (Paris); 2005 Jun; 66(3):264-9. PubMed ID: 15988389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndrome of resistance to thyroid hormone: insights into thyroid hormone action.
    Kopp P; Kitajima K; Jameson JL
    Proc Soc Exp Biol Med; 1996 Jan; 211(1):49-61. PubMed ID: 8594618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel TR beta mutation (R383H) in resistance to thyroid hormone syndrome predominantly impairs corepressor release and negative transcriptional regulation.
    Clifton-Bligh RJ; de Zegher F; Wagner RL; Collingwood TN; Francois I; Van Helvoirt M; Fletterick RJ; Chatterjee VK
    Mol Endocrinol; 1998 May; 12(5):609-21. PubMed ID: 9605924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone.
    Safer JD; Cohen RN; Hollenberg AN; Wondisford FE
    J Biol Chem; 1998 Nov; 273(46):30175-82. PubMed ID: 9804773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3'-triiodothyroinine binding affinity.
    Yagi H; Pohlenz J; Hayashi Y; Sakurai A; Refetoff S
    J Clin Endocrinol Metab; 1997 May; 82(5):1608-14. PubMed ID: 9141558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to thyroid hormone (RTH) syndrome reveals novel determinants regulating interaction of T3 receptor with corepressor.
    Yoh SM; Privalsky ML
    Mol Cell Endocrinol; 2000 Jan; 159(1-2):109-24. PubMed ID: 10687857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors.
    Yoh SM; Chatterjee VK; Privalsky ML
    Mol Endocrinol; 1997 Apr; 11(4):470-80. PubMed ID: 9092799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for helix 3 of the TRbeta ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone.
    Collingwood TN; Wagner R; Matthews CH; Clifton-Bligh RJ; Gurnell M; Rajanayagam O; Agostini M; Fletterick RJ; Beck-Peccoz P; Reinhardt W; Binder G; Ranke MB; Hermus A; Hesch RD; Lazarus J; Newrick P; Parfitt V; Raggatt P; de Zegher F; Chatterjee VK
    EMBO J; 1998 Aug; 17(16):4760-70. PubMed ID: 9707435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators.
    Tagami T; Gu WX; Peairs PT; West BL; Jameson JL
    Mol Endocrinol; 1998 Dec; 12(12):1888-902. PubMed ID: 9849963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone beta-receptors in thyroid hormone resistance syndrome.
    Collingwood TN; Adams M; Tone Y; Chatterjee VK
    Mol Endocrinol; 1994 Sep; 8(9):1262-77. PubMed ID: 7838159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T426I a new mutation in the thyroid hormone receptor beta gene in a sporadic patient with resistance to thyroid hormone and dysmorphism. Mutations in brief no. 192. Online.
    Menzaghi C; Di Paola R; Corrias A; Einaudi S; Trischitta V; De Sanctis C; De Filippis V
    Hum Mutat; 1998; 12(4):289. PubMed ID: 10660344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The thyroid hormone receptor-beta gene mutation R383H is associated with isolated central resistance to thyroid hormone.
    Safer JD; O'Connor MG; Colan SD; Srinivasan S; Tollin SR; Wondisford FE
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3099-109. PubMed ID: 10487671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear corepressors enhance the dominant negative activity of mutant receptors that cause resistance to thyroid hormone.
    Tagami T; Jameson JL
    Endocrinology; 1998 Feb; 139(2):640-50. PubMed ID: 9449636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant inheritance of resistance to thyroid hormone not linked to defects in the thyroid hormone receptor alpha or beta genes may be due to a defective cofactor.
    Weiss RE; Hayashi Y; Nagaya T; Petty KJ; Murata Y; Tunca H; Seo H; Refetoff S
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4196-203. PubMed ID: 8954015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors?
    Hayashi Y; Weiss RE; Sarne DH; Yen PM; Sunthornthepvarakul T; Marcocci C; Chin WW; Refetoff S
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3246-56. PubMed ID: 7593433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of CpG dinucleotides located in the triiodothyronine (T3)-binding domain of the thyroid hormone receptor (TR) beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone.
    Hayashi Y; Sunthornthepvarakul T; Refetoff S
    J Clin Invest; 1994 Aug; 94(2):607-15. PubMed ID: 8040316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to thyroid hormone in a patient without thyroid hormone receptor mutations.
    Parikh S; Ando S; Schneider A; Skarulis MC; Sarlis NJ; Yen PM
    Thyroid; 2002 Jan; 12(1):81-6. PubMed ID: 11838736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of eight new mutations in the c-erbAB gene of patients with resistance to thyroid hormone].
    Margotat A; Sarkissian G; Malezet-Desmoulins C; Peyrol N; Vlaeminck Guillem V; Wémeau JL; Torresani J
    Ann Endocrinol (Paris); 2001 Jun; 62(3):220-5. PubMed ID: 11458173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological Interactions Between Mutant Thyroid Hormone Receptors and Corepressors and Their Modulation by a Thyroid Hormone Analogue with Therapeutic Potential.
    Harrus D; Déméné H; Vasquez E; Boulahtouf A; Germain P; Figueira AC; Privalsky ML; Bourguet W; le Maire A
    Thyroid; 2018 Dec; 28(12):1708-1722. PubMed ID: 30235988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation (E333D) in the thyroid hormone beta receptor causing resistance to thyroid hormone syndrome.
    Maraninchi M; Bourcigaux N; Dace A; El-Yazidi C; Malezet-Desmoulins C; Krempf M; Torresani J; Margotat A
    Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):569-76. PubMed ID: 17177139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.